Revance Therapeutics Inc (RVNC)

[edcoolidge]

I suspect between likely no rate cuts this year, a difficult balance sheet, a week Q1, and distrust of Foley, we will see RVNC in the $2's this year. Revance is priced for likely bankruptcy. They're hardly alone. Nobody wants to own unprofitable small caps with debt in this environment. Many of these companies will go bankrupt. If Revance doesn't then we will likely look back on the current share price as an excellent opportunity. The RVNCQ clowns on this board want to convince everyone that the share price collapse is proof Daxxify "doesn't work" or is inferior to other toxins. That's wrong.